Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial.
暂无分享,去创建一个
H. Putter | S. Oerlemans | E. M. van der Steen-Banasik | S. D. de Boer | I. Jürgenliemk-Schulz | R. Nout | A. Slot | J. Mens | H. Nijman | C. Creutzberg | J. Jobsen | L. Lutgens | K. W. Verhoeven-Adema | M. C. Stenfert Kroese | S. M. de Boer | K. Verhoeven-Adema
[1] D. Gaffney,et al. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers. , 2015, Gynecologic oncology.
[2] Gaetano Rocco,et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Danièle Williaume,et al. Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: results of the phase II RTCMIENDOMETRE French multicentre trial. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] K. Pennert,et al. Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial , 2013, The Lancet.
[5] S. Zimmerman,et al. Assessing the impact of cancer among Dutch non‐Hodgkin lymphoma survivors compared with their American counterparts: a cross‐national study , 2013, Psycho-oncology.
[6] P. Ganz,et al. A procedure for obtaining Impact of Cancer version 2 scores using version 1 responses , 2013, Quality of Life Research.
[7] H. Putter,et al. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. , 2012, European journal of cancer.
[8] P. Fayers,et al. Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2012, European journal of cancer.
[9] Jae‐Young Lim,et al. Effect of a pelvic floor muscle training program on gynecologic cancer survivors with pelvic floor dysfunction: a randomized controlled trial. , 2012, Gynecologic oncology.
[10] C. Muller,et al. A pilot randomized control trial to evaluate pelvic floor muscle training for urinary incontinence among gynecologic cancer survivors. , 2012, Gynecologic oncology.
[11] Lonneke V van de Poll-Franse,et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J. Roovers,et al. Long-term cervical cancer survivors suffer from pelvic floor symptoms: a cross-sectional matched cohort study. , 2010, Gynecologic oncology.
[13] H. Putter,et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial , 2010, The Lancet.
[14] C. Gillham,et al. An overview of a prospective randomised phase II trial evaluating adjuvant pelvic radiotherapy using either IMRT or 2-dimensional virtual simulation planning for early stage endometrial cancer [ICORG 09-06] , 2010 .
[15] Gunnar Steineck,et al. Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. , 2010, European journal of cancer.
[16] Hein Putter,et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] T. Whelan,et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis , 2009, The Lancet.
[18] P. Ganz,et al. Refinement and psychometric evaluation of the impact of cancer scale. , 2008, Journal of the National Cancer Institute.
[19] S. Fosså,et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. , 2008, European journal of cancer.
[20] H. Geinitz,et al. Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] P. Ganz,et al. Assessing the impact of cancer: development of a new instrument for long‐term survivors , 2006, Psycho-oncology.
[22] M. Maiman,et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. , 2004, Gynecologic oncology.
[23] A. Bottomley,et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer. , 2003, European journal of cancer.
[24] P. Koper,et al. The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial. , 2001, International journal of radiation oncology, biology, physics.
[25] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. , 2000 .
[26] P. Koper,et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial , 2000, The Lancet.
[27] P. Carroll,et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. , 1995, International journal of radiation oncology, biology, physics.
[28] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[29] R. M. Hicks,et al. The subcellular basis of damage to the human urinary bladder induced by irradiation , 1984, The Journal of pathology.
[30] V. Abeler,et al. Postoperative External Irradiation and Prognostic Parameters in Stage I Endometrial Carcinoma: CLINICAL AND HISTOPATHOLOGIC STUDY OF 540 PATIENTS , 1980, Obstetrics and gynecology.
[31] P. Fayers,et al. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] D. Osoba,et al. Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.